Pular para o conteúdo
Merck
  • Hippo signaling mediates proliferation, invasiveness, and metastatic potential of clear cell renal cell carcinoma.

Hippo signaling mediates proliferation, invasiveness, and metastatic potential of clear cell renal cell carcinoma.

Translational oncology (2014-06-11)
Ute Schütte, Savita Bisht, Lukas C Heukamp, Moritz Kebschull, Alexandra Florin, Jens Haarmann, Per Hoffmann, Gerd Bendas, Reinhard Buettner, Peter Brossart, Georg Feldmann
RESUMO

Recent work has identified dysfunctional Hippo signaling to be involved in maintenance and progression of various human cancers, although data on clear cell renal cell carcinoma (ccRCC) have been limited. Here, we provide evidence implicating aberrant Hippo signaling in ccRCC proliferation, invasiveness, and metastatic potential. Nuclear overexpression of the Hippo target Yes-associated protein (YAP) was found in a subset of patients with ccRCC. Immunostaining was particularly prominent at the tumor margins and highlighted neoplastic cells invading the tumor-adjacent stroma. Short hairpin RNA-mediated knockdown of YAP significantly inhibited proliferation, migration, and anchorage-independent growth of ccRCC cells in soft agar and led to significantly reduced murine xenograft growth. Microarray analysis of YAP knockdown versus mock-transduced ccRCC cells revealed down-regulation of endothelin 1, endothelin 2, cysteine-rich, angiogenic inducer, 61 (CYR61), and c-Myc in ccRCC cells as well as up-regulation of the cell adhesion molecule cadherin 6. Signaling pathway impact analysis revealed activation of the p53 signaling and cell cycle pathways as well as inhibition of mitogen-activated protein kinase signaling on YAP down-regulation. Our data suggest CYR61 and c-Myc as well as signaling through the endothelin axis as bona fide downstream effectors of YAP and establish aberrant Hippo signaling as a potential therapeutic target in ccRCC.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Álcool etílico, puro, 200 proof, for molecular biology
Sigma-Aldrich
Álcool etílico, puro, 200 proof, ACS reagent, ≥99.5%
Sigma-Aldrich
Álcool etílico, puro, 200 proof, HPLC/spectrophotometric grade
Sigma-Aldrich
Álcool etílico, puro, 200 proof, meets USP testing specifications
Sigma-Aldrich
Álcool etílico, puro, 190 proof, for molecular biology
Sigma-Aldrich
Álcool etílico, puro, 200 proof, anhydrous, ≥99.5%
Sigma-Aldrich
Etanol, BioUltra, for molecular biology, ≥99.8%, (absolute alcohol, without additive, A15 o1)
Sigma-Aldrich
Etanol, ACS reagent, prima fine spirit, without additive, F15 o1
Sigma-Aldrich
Etanol, purum, absolute ethanol, denaturated with 4.8% isopropanol, A15 IPA1, ≥99.8% (based on denaturant-free substance)
Sigma-Aldrich
Álcool etílico, puro, 190 proof, ACS spectrophotometric grade, 95.0%
Sigma-Aldrich
Etanol, purum, fine spirit, denaturated with 4.8% methanol, F25 METHYL1, ~96% (based on denaturant-free substance)
Supelco
Ethanol solution, certified reference material, 2000 μg/mL in methanol
Supelco
Etanol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Etanol, purum, absolute ethanol, denaturated with 2% 2-butanone, A15 MEK1, ≥99.8% (based on denaturant-free substance)
Sigma-Aldrich
Etanol, purum, fine spirit, denaturated with 2% 2-butanone, F25 MEK1, ~96% (based on denaturant-free substance)
Sigma-Aldrich
Etanol, purum, absolute ethanol, denaturated with 1% cyclohexane, A15 CYCLO1, ≥99.8% (based on denaturant-free substance)
Sigma-Aldrich
Etanol, purum, secunda spirit, denaturated with 2% 2-butanone, S15, ~96% (based on denaturant-free substance)
Sigma-Aldrich
Álcool etílico, puro, 190 proof, ACS reagent, meets USP testing specifications, Excise Tax-free, Permit for use required
Sigma-Aldrich
Álcool etílico, puro, 160 proof, Excise Tax-free, Permit for use required
Sigma-Aldrich
MISSION® esiRNA, targeting human YAP1
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Yap1
Sigma-Aldrich
MISSION® esiRNA, targeting human YY1AP1